冷凍乾燥注射劑的全球市場規模、佔有率、成長分析（按藥物、按適應症）-產業預測，2023-2030年

Global Lyophilized Injectable Drugs Market Size, Share, Growth Analysis, By Drug(Anti-infective, Anti-neoplastic), By Indication(Autoimmune diseases, Respiratory diseases) - Industry Forecast 2023-2030

出版日期: 2024年02月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球冷凍乾燥注射劑市場規模預計為30.9億美元，在預測期內（2024-2031年）從2023年的33.9億美元成長到2031年的54.4億美元，預計複合年成長率為6.5%。

全球冷凍乾燥注射藥物市場提供經過冷凍乾燥以形成適合注射的穩定粉末狀製劑的藥品。這個過程通過去除水分來延長藥物的保存期限，使它們更容易儲存和運輸。由於降低污染風險和維持藥效的好處，該市場正在經歷顯著成長。冷凍乾燥注射劑應用於感染疾病、腫瘤、自體免疫疾病等各個治療領域。在製造過程中，藥物溶液被冷凍，然後在真空下昇華以獲得乾粉。市場的一個關鍵促進因素是對更穩定配方的需求，特別是對於容易分解的生技藥品和複雜分子。醫療保健提供者更喜歡這些藥物，因為它們的保存期限更長並減少浪費。此外，凍乾藥品在緊急情況下或在資源有限且缺乏冷藏的環境中具有優勢。然而，也存在一些挑戰，例如需要專用設備和增加的製造成本。冷凍乾燥藥物重建的錯誤可能會影響藥物療效和病人安全，需要適當的培訓，並浪費時間和資源。儘管存在這些障礙，冷凍乾燥技術的持續進步、擴大新治療領域的研究以及提高藥物穩定性的努力預計將維持市場成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Pfizer Inc.
Novartis AG
Roche Holding AG
Johnson & Johnson
Sanofi SA
Amgen Inc.
AbbVie Inc.
Merck & Co., Inc.
Eli Lilly and Company
AstraZeneca PLC
Bristol Myers Squibb Company
GlaxoSmithKline plc
Gilead Sciences, Inc.
Biogen Inc.
Teva Pharmaceutical Industries Ltd.
Mylan NV
Celgene Corporation
Novo Nordisk A/S
Vertex Pharmaceuticals Incorporated
Takeda Pharmaceutical Company Limited

簡介目錄

Product Code: SQMIG35B2145

Global Lyophilized Injectable Drugs Market size was valued at USD 3.09 Billion in 2022 and is poised to grow from USD 3.39 Billion in 2023 to USD 5.44 Billion by 2031, at a CAGR of 6.5% during the forecast period (2024-2031).

The global market for lyophilized injectable drugs offers pharmaceutical products that have undergone freeze-drying to create stable, powder-like formulations suitable for injection. This process extends the shelf life of medications by removing water content, facilitating convenient storage and transportation. The market has experienced significant growth due to its benefits in reducing contamination risk and preserving drug efficacy. Lyophilized injectable drugs find application across various therapeutic areas such as infectious diseases, oncology, autoimmune disorders, and more. The manufacturing process involves freezing the drug solution, followed by sublimation under vacuum to obtain a dry powder that can be reconstituted into liquid form using a suitable solvent prior to administration. A key driver for the market is the demand for more stable formulations, particularly for biologics and complex molecules prone to degradation. Healthcare providers favor these drugs due to their extended shelf life, reducing wastage. Additionally, lyophilized drugs offer advantages in emergency situations and environments lacking refrigeration due to limited resources. Nevertheless, challenges such as the need for specialized equipment and higher production costs exist. Errors in reconstituting lyophilized drugs can affect medication effectiveness and patient safety, necessitating proper training and potentially wasting time and resources. Despite these obstacles, ongoing advancements in lyophilization techniques, expanding research in new therapeutic areas, and efforts to enhance drug stability are expected to sustain market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lyophilized Injectable Drugs and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Lyophilized Injectable Drugs Market Segmental Analysis

The global lyophilized injectable drugs market is segmented by Drug, Indication, Delivery, Packaging, Distribution Channel, and Region. Based on Drug the market is segmented as, Anti-infective, Anti-neoplastic, Anticoagulant, Hormones, Antiarrhythmic, Others. Based on Indication the market is segmented as, autoimmune diseases, respiratory diseases, gastrointestinal disorders, Oncology, Cardiovascular diseases, Infectious diseases, Metabolic disorders, others. Based on Delivery the market is segmented as, Prefilled diluent syringes, Multi-step devices. Based on Packaging the market is segmented as, Vials, Cartridges, and Prefilled devices. Based on Distribution Channel the market is segmented as, Hospital pharmacy, Retail pharmacy, and online pharmacy. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA).

Drivers of the Global Lyophilized Injectable Drugs Market

The rising demand for lyophilized injectable drugs is driven by the growing use of peptides, biologics, and other complex molecules in therapies. These drugs often require stable formulations to preserve their efficacy, given their delicate nature.

The process of lyophilization extends the shelf life of therapeutic drugs by removing water content and improving drug stability. Healthcare providers and pharmaceutical manufacturers seeking products with extended storage periods are particularly drawn to this advantageous characteristic.

Restraints in the Global Lyophilized Injectable Drugs Market

Market Trends of the Global Lyophilized Injectable Drugs Market

Increase in Biologics and Complex Molecules: The market witnessed a rise in the development and utilization of peptides, biologics, and other complex molecules across different therapeutic areas. Lyophilization plays a crucial role in preserving the stability of these fragile molecules, ensuring their efficacy upon reconstitution, a critical factor in the industry.

Innovations in Drug Delivery: Technological advancements have led to improvements in drug delivery systems for lyophilized injectables. This includes the development of user-friendly devices and reconstitution mechanisms, enhancing patient convenience.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Lyophilized Injectable Drugs Market by Drug

Market Overview
Anti-infective
Anti-neoplastic
Anticoagulant
Hormones
Antiarrhythmic
Others

Global Lyophilized Injectable Drugs Market by Indication

Market Overview
Autoimmune diseases
Respiratory diseases
Gastrointestinal disorders
Oncology
Cardiovascular diseases
Infectious diseases
Metabolic disorders
and Others

Global Lyophilized Injectable Drugs Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol Myers Squibb Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gilead Sciences, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celgene Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vertex Pharmaceuticals Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments